Background {#Sec1}
==========

Leishmaniases are parasitic diseases caused by kinetoplastid protozoans of the family Trypanosomatidae, transmitted by the bite of infected female sand flies belonging to the genera *Phlebotomus* and *Lutzomyia* in the Old and New World, respectively \[[@CR1]\]. Three main clinical forms of leishmaniasis are reported worldwide: cutaneous leishmaniasis (CL), visceral leishmaniasis (VL) and mucocutaneous leishmaniasis (MCL). They occur in 98 countries and, according to the World Health Organization (WHO), leishmaniasis affects 12 million people worldwide with approximately 0.2--0.4 million VL cases and 0.7--1.2 million CL cases diagnosed each year. In Morocco, CL is a major public health problem, with two main causative entities: the zoonotic form due to *Leishmania major* and the anthroponotic form due to *Leishmania tropica* \[[@CR2]\]. Cutaneous lesions caused by these species are associated with a clinical polymorphism with respect to aspect, incubation period and healing time \[[@CR3]\].

The parasite life-cycle involves two stages: the promastigote insect stage and the amastigote vertebrate stage. Promastigotes replicate and differentiate in the gut of hematophagous female sand fly vectors that inoculate metacyclic promastigotes into the mammalian host's dermis when feeding. *Leishmania* parasites infect immune cells, particularly phagocytes, such as neutrophils, dendritic cells and particularly macrophages. Thus, the promastigotes develop into amastigotes, which multiply inside parasitophorous' vacuoles in phagocytes \[[@CR4]\].

*Leishmania* drastically alters the normal macrophage physiology, by modulating numerous signaling pathways \[[@CR4]\]. For instance, we and others have reported that *Leishmania* species block apoptosis of their host cells, thus extending their viability \[[@CR5], [@CR6]\]. *In vitro* studies have also demonstrated that parasites modulate nitric oxide (NO) production, which exerts a leishmanicidal activity on promastigotes and amastigotes by inducing an apoptotic cell death program \[[@CR7]--[@CR9]\]. In murine systems, pro-inflammatory cytokines such as IFN-γ or TNFα, or endotoxins such as LPS, induce activation of iNOS, resulting in the elimination of intracellular parasites \[[@CR10]\]. Mice deficient for iNOS are more sensitive to *L. major* or *L. donovani* infection. Moreover, the C57BL/6 mice resistance correlates with the ability of macrophages to produce NO following activation. In contrast, BALB/c mice are susceptible to *L. major* infection due to the lower level of iNOS activation and NO production by macrophages \[[@CR7], [@CR11]\]. Furthermore, it has been shown that *L. amazonensis*-infection of C57BL/6 mice is controlled via NO and reactive oxygen species (ROS) produced by macrophages \[[@CR12]\]. In patients infected with *L. tropica*, biopsies and serosities sampled at early stages of the infection showed early iNOS expression and presence of NO in the sera; similar observations are reported in patients infected by *L. donovani* \[[@CR13], [@CR14]\]. In contrast, other species have developed a resistance to NO produced by activated macrophages such as *L. chagasi* promastigotes \[[@CR15], [@CR16]\]. Because the maintenance of *Leishmania* spp. *in vitro* results in a progressive loss of virulence \[[@CR17]\], it is of crucial importance to use primary isolates for assessing CL pathogenicity.

Thus, our aim was to determine whether the pathogenicity of clinical *L. major* or *L. tropica* primary isolates from Moroccan patients is related to a difference in (i) their capacity to modulate the NO production by macrophages, and/or (ii) their susceptibility to exogenous NO.

Methods {#Sec2}
=======

*Leishmania* strains {#Sec3}
--------------------

*Leishmania major* (MHOM/MA/2010/L112) and *L. tropica* (MHOM/MA/2010/L02) strains were isolated from skin lesions of Moroccan CL patients diagnosed in the Department of Dermatology (Ibn Rochd Hospital of Casablanca, Morocco). The dermal syringe-sucked fluid was collected under sterile conditions from the border of active skin lesions from each patient as follows: the lesions were cleaned with alcohol, and 0.1 to 0.2 ml of sterile saline solution was injected using a 1 ml syringe (25-gauge needle) into the nodule and the needle was rotated gently several times. A small amount of saline solution was injected into the tissue, and then aspirated. They were subsequently directly genotyped in the Parasitology Laboratory at the Casablanca Faculty of Medicine and Pharmacy according to Mouttaki et al. \[[@CR18]\]. The promastigotes were isolated in NNN biphasic medium and then grown and maintained at 26 °C in RPMI-1640 medium (Gibco, Essonne, France) supplemented with 10% heat-inactivated fetal calf serum (Gibco), 2 mM L-glutamine (Gibco), 100 U/ml penicillin (Gibco), and 100 ng/ml streptomycin (Gibco). *Leishmania major* and *L. tropica* promastigotes were used after 5 successive in vitro passages.

Soluble *Leishmania* promastigotes antigens (SLAs) {#Sec4}
--------------------------------------------------

SLAs were prepared from stationary phase promastigotes of *L. major* and *L. tropica* strains as described by \[[@CR19]\]. Briefly, the promastigotes were washed 3 times in cold sterile phosphate-buffered saline (PBS) and then adjusted to 10^8^ promastigotes/ml in PBS. The parasites were disrupted by ten cycles of freezing (-80 °C) and thawing (37 °C) followed by ultra-sonication (20 times for 10 s). SLAs were aliquoted and stored at -80 °C until use. The protein concentration was determined by Bradford protein assay (Protein Assay kit, BioRad, New York, USA).

*In vitro* infection of the murine J774 cell line by *Leishmania* promastigotes {#Sec5}
-------------------------------------------------------------------------------

The murine macrophage J774 cell line, cultured at 37 °C at 5% CO~2~, was seeded at the density of 5.10^5^ cells/well in 24-well culture plates on round 12 mm diameter cover-slips (Greiner Bio-One International, Frickenhausen, Germany). After overnight culture, promastigotes were added at ratio 10 and 5 parasites per macrophage (ratio 10:1 and 5:1) and incubated at 37 °C for 4 h. Infected cells were washed 3 times with sterile PBS to remove extracellular promastigotes. The coverslips were removed from the plates and stained with Giemsa dye 24 and 48 h post-infection. Infected cells and intracellular parasites were counted in ten fields under a light microscope by two independent observers. The rate of infected macrophages was calculated as follows: (Number of infected macrophages/Total number of macrophages) × 100. The amastigote infection rates were estimated by the mean number of intracellular amastigotes in 100 cells.

Promastigotes viability control in LPS/IFN-γ stimulated macrophages {#Sec6}
-------------------------------------------------------------------

The murine macrophage J774 cell line was cultured as described above. After 48 h post-infection the supernatant was removed and cells were washed and then incubated with 0.01% SDS for 10 min to allow release of live parasites. Then 1 ml of RPMI-1640 medium supplemented with 10% FCS was added to each well, and the plate was incubated at 26 °C for 3 days. The relative intracellular load of parasites was measured by assessing the number of extracellular motile promastigotes produced in medium using the Trypan blue exclusion assay.

Nitric oxide (NO) production {#Sec7}
----------------------------

The cells were stimulated in the absence or presence of either IFN-γ (10 ng/ml) (Sigma-Aldrich, Taufkirchen, Germany) and Lipopolysaccharide (LPS) (50 ng/ml) (Sigma-Aldrich) in presence or absence of N^G^-Methyl-L-arginine acetate salt (L-NMMA) (1 mg/ml) (Sigma-Aldrich). The cells were also stimulated with SLAs (10 μg/ml or 20 μg/ml). Supernatants were collected 24 and 48 h post-stimulation and stored at -20 °C until use for nitrite assay.

Nitrite (NO~2~ ^−^) is a stable compound produced by the reaction of NO with water and oxygen, and its accumulation reflects the amount of NO produced in culture medium. NO~2~ ^−^ assay was performed according to Griess protocol previously described \[[@CR20]\]. Briefly, 100 μl of supernatants were distributed to 96-well plates in triplicates and 100 μl of Griess reagent (1% sulfanilamide, 0.1% N-(1-Naphthyl) ethylenediamine dihydrochloride and 2.5% H~3~PO~4~) (Sigma-Aldrich) was added. The plates were incubated at room temperature and optical density (OD) was read at 540 nm using a BioRad Micro-plate Reader Photometer (BioRad Dynex, Washington, USA). The NO concentration was calculated from a standard curve generated with NaNO~2~ ranging from 0 to 200 μM. The experiments were performed in triplicates and the results represent the average of 6 independent experiments.

Impact of exogenous NO on parasite viability {#Sec8}
--------------------------------------------

### Promastigote viability {#Sec9}

Promastigotes at stationary phase were incubated at 5.10^5^ parasites/well in 96-well plates in the presence of different concentrations of S-Nitroso-N-acetylpenicillamine (SNAP) (Sigma-Aldrich), and N-acetyl-D-L-penicillamine (NAP) (Sigma-Aldrich) ranging from 25 to 100 μM. The plates were incubated at 26 °C for 24 h and the viability rate was determined by MTT assay. Briefly, 10 μl of MTT reagent (5 mg/ml) \[3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyltetiazolium bromide\] (Sigma-Aldrich) was added and incubated at 26 °C for 4 h. Solubilization of the formed formazan crystals was performed by using 100 μl of acidic isopropanol 0.04 N and 50 μl of DMSO. After incubation for 15 min at room temperature; the OD was measured at 570 nm using a BioRad Micro-plate Reader Photometer (BioRad Dynex, Washington, USA). The promastigote viability index was assessed as following: (absorbance of treated promastigotes/absorbance of control promastigotes) × 100. The 50% inhibitory concentration (IC~50~), i.e. the SNAP concentration that decreases the growth by 50%, was calculated by regression analysis \[[@CR21]\]. Results represent the average of 6 independent experiments.

### Amastigote viability {#Sec10}

Cell monolayers of infected macrophages treated or untreated with SNAP for 24 h were washed and incubated with 0.01% SDS for 10 min to allow release of live amastigotes. 1 ml of RPMI-1640 medium supplemented with 10% FCS was added to each well, and the plate was incubated at 26 °C for 2 days. The relative intracellular load of amastigotes was measured by assessing the number of extracellular motile promastigotes produced in the medium \[[@CR22]\].

Statistical analysis {#Sec11}
--------------------

Data are represented as mean ± SEM. The significance of the results was calculated using one-way ANOVA analysis of variance with Tukey's *post-hoc* test for multiple comparisons was implemented using GraphPad Prism version 5.0. The threshold of significance was fixed at *P* \< 0.05.

Results {#Sec12}
=======

The clinical phenotypes of patients from which the two primary strains of *L. major* (MHOM/MA/2010/L112) and *L. tropica* (MHOM/MA/2010/L02) were isolated are summarized in Table [1](#Tab1){ref-type="table"}. Both strains were isolated from patients living in Casablanca, a non-endemic area for CL. They were both infected during a summer staying in known endemic foci of CL due to *L. tropica* or *L. major*.Table 1Clinical profile of patients from which the two strains were isolatedStrainsMHOM/MA/2010/L02MHOM/MA/2010/L112PatientsPatient 1Patient 2Age (years)521SexFemaleMaleResidence cityCasablancaCasablancaMain clinical data: Number of dermal lesions15 Incubation time (months)11--3^a^ Evolution time of lesions at diagnosis (months)42 Evolution of lesions upon treatmentFavorable but needed more than a single cureFavorableGenotyping*L. tropicaL. major*^a^The exact incubation time could not be determined because the patient reported two distinct staying periods in endemic foci

Infection of the J774 cell line by *L. major* and *L. tropica* primary strains {#Sec13}
------------------------------------------------------------------------------

To compare the infectivity of both *L. major* and *L. tropica* primary isolates, we employed the well-established J774 cell line as a model for *Leishmania* infection. The percentage of macrophages infected by *L. major* and *L. tropica* strains was 60 and 68%, respectively. No significant difference was observed when comparing the percentage of infected cells at 24 h post-infection (Fig. [1a](#Fig1){ref-type="fig"}) and 48 h post-infection (Fig. [1b](#Fig1){ref-type="fig"}). Furthermore, we did not observe any major difference at either a 10:1 or 5:1 parasite-to-host cell ratios. For both infection ratios, we found an average 3--4 amastigotes/cell (Table [2](#Tab2){ref-type="table"}) and these values were similar for both strains. Thus our results show no difference in the infectivity of both *L. major* and *L. tropica* strains*.* Fig. 1Percentage of *J774* macrophage-like cells infected by *L. major* and *L. tropica* strains. After 24 h (**a**) and 48 h (**b**) of culture, the percentage of infected cells per 100 cells was quantified microscopically. Results are expressed as mean ± SEM from three independent experiments, each performed in duplicate. Data were analyzed using one way ANOVA test with Tukey's *post-hoc* test for multiple comparisons. *Abbreviation*: ns, not significant Table 2Amastigote infection rates of J774-macrophages (mean ± SEM)^a^*L. tropica* strain*L. major* strainRatio10:15:110:15:1Incubation time 24 h4.0 ± 0.33.0 ± 0.33.0 ± 0.33.0 ± 0.3 48 h3.0 ± 0.23.0 ± 0.34.0 ± 0.33.5 ± 0.5^a^Results are expressed as mean ± SEM from three independent experiments

Modulation of NO production by *L. major* and *L. tropica* promastigotes {#Sec14}
------------------------------------------------------------------------

We next wanted to assess whether the two primary *L. major* and *L. tropica* clinical isolates strains modulate the NO production by macrophages. Macrophages were infected at two ratios (10:1 and 5:1), and stimulated with IFN-γ and LPS. Nitrite concentrations in supernatants were measured at 24 and 48 h post-infection. In the absence of stimulation, none of the strains induced NO production (Fig. [2a, b](#Fig2){ref-type="fig"}). Stimulated uninfected macrophages produced levels of NO ranging from 29 to 42 μM at 24 h (*F* ~(3,20)~ = 30.81, *P =* 0.003) and 48 h (*F* ~(3,20)~ = 42.36, *P =* 0.002), respectively. In the presence of L-NMMA, an iNOS inhibitor, NO production was suppressed, thus showing the specificity of the measurement. The results obtained with 5:1 ratio did not differ from 10:1 results. So, we presented only 10:1 ratio results.Fig. 2Effect of *L. major* and *L. tropica* promastigotes on NO production by macrophages. Macrophages were infected with 10 promastigotes of *L. tropica* or *L. major* /cell for 4 h. Cells were kept either without stimulus or stimulated with IFN-γ (10 ng/ml) and LPS (50 ng/ml) in presence or absence of L-NMMA (1 mg/ml). The supernatants were collected and nitrite concentrations were evaluated by Griess reaction at 24 h post-infection (**a**) and 48 h post-infection (**b**). Results are expressed as mean ± SEM from six independent experiments, each performed in duplicate. Data were analyzed using one way ANOVA test with Tukey's *post-hoc* test for multiple comparisons. \**P* \< 0.05, *\*\*P* \< 0.01. *Abbreviation*: ns, not significant

Our results showed that *L. tropica* infection significantly reduced the production of NO induced by IFN-γ and LPS at 24 h (*F* ~(2,15)~ = 7.01, *P =* 0.04) and 48 h (*F* ~(2,15)~ = 9.33, *P =* 0.002), compared to stimulated non-infected cells. In contrast, infection with *L. major* had no impact on NO production after stimulation (Fig. [2a, b](#Fig2){ref-type="fig"}). Therefore, our results show that primary autochthonous *L. major* and *L. tropica* strains differentially modulate IFN-γ and LPS-induced NO production by macrophages*.*

Promastigotes viability control in LPS/IFN-γ stimulated macrophages {#Sec15}
-------------------------------------------------------------------

The *L. tropica* and *L. major* viability control was investigated in macrophages after stimulation. As shown in Fig. [3](#Fig3){ref-type="fig"}, the number of viable *L. tropica* promastigotes after stimulation was significantly increased compared to in unstimulated macrophages (*F* ~(3,20)~ = 8.21, *P =* 0.035). Thus, the high NO inhibition by *L. tropica* promastigotes shown in Fig. [2](#Fig2){ref-type="fig"} is associated with a significant parasite load. However, in *L. major*-infected macrophages, there was no difference in parasite number between stimulated and unstimulated cells.Fig. 3Number of *L. tropica* and *L. major* promastigotes in LPS/IFN-γ activated macrophages. Number of extracellular motile promastigotes was counted after 72 h incubation using the Trypan blue exclusion assay. Results are presented as mean ± SEM from three independent experiments, each performed in duplicate. Data were analyzed using one way ANOVA test with Tukey's *post-hoc* test for multiple comparisons. *\*P* \< 0.05. *Abbreviation*: ns: not significant

Modulation of NO production by *L. major* and *L. tropica* SLAs {#Sec16}
---------------------------------------------------------------

Several components derived from parasites, such as the surface glycolipid lipophosphoglycan (LPG) and the metalloprotease GP63 which impact on phagosome and function of the NADPH oxidase complex, modulate intracellular signaling \[[@CR23]\]. Furthermore, the protein tyrosine phosphatase SHP-1 (Src-homology 2 domain containing phosphatase-1) has been reported to inhibit NO production \[[@CR24]\]. Therefore, we decided to determine whether soluble *Leishmania* antigens (SLAs), derived from either *L. major* or *L. tropica* strains, modulate NO production. Thus, SLAs from *L. tropica* and *L. major* significantly inhibited the production of NO by J774 (Fig. [4a, b](#Fig4){ref-type="fig"}). However, unlike infection with live parasites, no difference was observed between the two strains. These results suggest that distinct parasite factors and distinct mechanisms are responsible for inhibition of NO production by the two strains studied.Fig. 4Effect of *L. major* and *L. tropica* SLA on NO production by macrophages. The J774 macrophages cells were cultured in presence of *L. tropica* SLA (**a**), *L. major* SLA (**b**), and stimulated according to the same protocol than promastigotes. The supernatants were collected and nitrite concentrations were evaluated by Griess reaction after 24 h post-infection. Results are expressed as mean ± SEM from three independent experiments, each performed in duplicate. Data were analyzed using one way ANOVA test with Tukey's post-hoc test for multiple comparisons. *\*\*\*P* \< 0.001

*Leishmania major* and *L. tropica* susceptibility to exogenous NO {#Sec17}
------------------------------------------------------------------

NO is highly toxic to *Leishmania* parasites, leading to mitochondrial permeabilization and dysfunction. We employed the MTT assay to measure parasite viability in the presence of increasing concentrations of SNAP, a NO donor, compared to a control molecule, NAP. Given that the conversion of MTT to formazan is performed mostly by mitochondrial reductases, the assay also serves as a marker of mitochondrial activity.

Our results showed that SNAP significantly reduces the viability of promastigotes of both *L. tropica* and *L. major* strains, in a dose-dependent manner. Indeed at 25 μM (*F* ~(3,20)~ = 800.6, *P* = 0.002), 50 μM (*F* ~(3,20)~ = 800.6, *P* = 0.005) and 100 μM (*F* ~(3,20)~ = 800.6, *P* = 0.0019), the viability of *L. tropica* (Fig. [5a](#Fig5){ref-type="fig"}) and *L. major* (Fig. [5b](#Fig5){ref-type="fig"}) promastigotes was significantly reduced compared to control promastigotes (*F* ~(3,20)~ = 144, *P* = 0.0039). After 24 h of incubation, the viability decrease of *L. tropica* promastigotes was more important at the dose of 50 μM and 100 μM of SNAP. The IC~50~ of SNAP was 24 μM and 52 μM for *L. tropica* and *L.major* promastigotes, respectively (Fig. [5a, b](#Fig5){ref-type="fig"}).Fig. 5*Leishmania major* and *L. tropica* promastigotes and amastigotes sensitivity to exogenous NO. Viability of *L. tropica* promastigotes (**a**) and viability of *L. major* promastigotes (**b**) and amastigotes (**c**, **d**) was evaluated after 24 h incubation with different concentrations of SNAP and its control (NAP). In all experiments, the addition of NAP at the same concentrations as SNAP did not impact the viability of parasites (100% viability). Results are expressed as mean ± SEM from six independent experiments, each performed in duplicate. The NO release by SNAP was measured in the culture supernatant for each concentration. NO concentration ranges: **a** and **b**: 17.26--55.20 μM, **c** and **d**: 14.75--44.67 μM. Data were analyzed using one way ANOVA test with Tukey's *post-hoc* test for multiple comparisons.*\*\*P* \< 0.01, *\*\*\*P* \< 0.001. *Abbreviation*: ns: not significant

We then assessed the impact of SNAP on amastigote forms, which are the intracellular forms in infected host-cell targets. Our results demonstrated that both are significantly sensitive in a dose-dependent manner. The viability of *L. tropica* amastigotes decreased significantly at 25 μM, 50 μM and 100 μM (*F* ~(3,8)~ = 55, *P* = 0.0005). The viability of *L. major* amastigotes decreased significantly only at 50 μM (*F* ~(3,8)~ = 21.18, *P* = 0.002) and 100 μM (*F* ~(3,8)~ = 21.18, *P* = 0.0004). The viability decrease of *L. tropica* amastigotes was more significant than for *L. major* (Fig. [5c, d](#Fig5){ref-type="fig"}). The SNAP concentrations 25 μM and 50 μM did not have a significant effect on the viability of uninfected J774 macrophages (data not shown). The control molecule (NAP) had no effect on the viability of promastigotes and amastigotes of both strains (100% viability).

In order to verify NO release by SNAP, we measured the nitrite accumulation in the cultures supernatants at 24 h of incubation. These concentrations were correlated with the input amount of SNAP concentrations. Indeed, NO concentrations ranges were 17.26--55.20 μM for promastigotes and 14.75--44.67 μM for amastigotes. Thus, our results demonstrate that both promastigotes and amastigotes of *L. tropica* display higher sensitivity to exogenous NO compared to *L. major.*

Discussion {#Sec18}
==========

Cutaneous leishmaniasis remains a major public health problem in Morocco with thousands of new cases occurring each year. This number reached 8707 patients diagnosed in 2010, and owing to the control measures implemented by the Ministry of Health, this number decreased to 2555 in 2014 \[[@CR25]\]. Clinical manifestations of the infection depend upon the infecting *Leishmania* species and the efficacy of the host immune response to control and eliminate the parasite. The co-evolutionary process enabled *Leishmania* parasites to adapt and survive in the myeloid cell lineage \[[@CR26]\].

Herein, we demonstrate a differential ability to modulate macrophages NO production by two primary autochthonous *L. tropica* and *L. major* strains isolated from Moroccan patients. While both strains exhibit similar J774 macrophages-infectivity, the *L. tropica* strain has an increased capacity to inhibit NO production as compared with *L. major* strain. Our results further show that both *L. tropica* promastigotes and amastigotes are more sensitive to NO donor, than *L major* promastigotes and amastigotes. Conversely, *in vitro* studies have shown that the SNAP or S-nitrosoglutathione (GSNO) NO donors have a leishmanicidal activity on promastigotes and amastigotes of *L. major* or *L. amazonensis* \[[@CR27], [@CR28]\]. The local treatment of skin lesions of patients suffering from CL due to *L. major* with a SNAP-containing cream accelerates the healing process. Similarly, the GSNO was also used efficiently to locally treat ulcerated skin lesions in mice infected with *L. major* \[[@CR29]\]. Susceptible BALB/c mice infected with *L. major* and treated with NO donors (GSNO or trinitroglycerin) show a reduction in parasite burden at the infection site and a marked reduction in disease progression.

Although expression of NO might be a critical leishmanicidal marker, it has been reported that some parasite strains escape to this process. Human and canine *L. infantum* and *L. braziliensis* strains are resistant to NO released by exogenous donor, which is associated with the clinical worsening of human and canine leishmaniasis \[[@CR15], [@CR28]\]. Moreover, it has been shown that despite a strong expression of NO in the serum of CL patients due to *L. tropica* \[[@CR13], [@CR14]\] or iNOS in the spleen of *L. chagasi-*infected dogs, these infections are associated with a parasite burden increase \[[@CR30]\]. In murine macrophages infected either by *L. infantum* or *L. chagasi,* a high NO production was also associated with a significant parasite load, indicating that both species are able to survive and resist to NO produced in macrophages. Hence some *Leishmania* species are sensitive to NO while other species would be able to develop resistance to endogenous NO leading to a worsening course of the disease \[[@CR30], [@CR31]\].

Herein, we demonstrated that SNAP significantly reduces the viability of promastigote and amastigote forms of both strains in a dose-dependent manner. However, the *L tropica* strain was more sensitive than *L major* strain. It has been proposed that the clinical diversity of CL dermal lesions results not only from the different parasite species involved or the type of the zoonotic cycle concerned but also the immunological status and the genetic background of the patients \[[@CR32], [@CR33]\]. *Leishmania tropica* clinical strains were isolated from a 5 years old girl living in Casablanca that spent her holidays in a known endemic focus of CL. One cutaneous lesion appeared 1 month later and she consulted 4 months later. The delayed healing process of the lesion led to several cures. Healing of lesions due to *L. tropica* may last more than 1 year, confirming the chronic tendency of this form of CL. Relapses and treatment failures are also not exceptional for this pathology \[[@CR1], [@CR34]\]. The second patient presented 5 dermal lesions that healed correctly under the standard treatment. The classical lesion caused by *L. major* is of "wet" type and heals within 2--8 months \[[@CR34], [@CR35]\]. Although we cannot exclude that host factors, such as age, may have contributed to a long healing process that needed more than one cure, it may also be due to a more virulent *L. tropica* strain. Furthermore we showed the increased ability of this *L. tropica* strain to alter NO production. If our ongoing assays on other Moroccan *L. tropica* strains confirm this tendency, we could consider that this intrinsic character may foster the geographical spread of *L. tropica* throughout Morocco reported since the 1990s; *L. tropica* foci were limited to central south regions in the 1980s \[[@CR1]\].

Our results indicate that the reduction of NO production by *L. tropica* infected and stimulated macrophages is associated with a significant increase of motile promastigotes produced by these cells. This may suggest that the intracellular macrophage control of the *L. tropica* strain do not only rely on NO. Other key molecules, like ROS, are involved in the macrophage-mediated innate host defense against *Leishmania*. Despite several studies on ROS and NO species in *Leishmania* killing, their mechanism is still misunderstood. On the other hand, it has been reported that some inflammatory cytokines produced by infected phagocytes shifts the L-arginine metabolism towards the production of L-ornithine and urea through arginase activation, leading to a decrease in NO secretion that fosters intracellular *Leishmania* growth. Furthermore it was reported that IFN-γ can act as a growth factor within macrophages for some *Leishmania* species (i.e. *L. amazonensis*). Thus the subversion of NO production by *Leishmania* is well recognized as a mechanism of immune escape, allowing the parasite to survive for a longer time \[[@CR7]\].

A large number of studies have implicated the importance of glycoconjugates in New or Old World *Leishmania* biology. These glycoconjugates include LPG, glycoinositolphospholipids (GIPLs), gp63 and the proteophosphoglycan (PPG). It is well documented that glycoconjugate interspecies polymorphism is important for the differential regulation of initial events of the immune response, as well as in the establishment of the infection \[[@CR36]\]. LPG from *L. major* induced the production of IFN-γ and the expression of iNOS, resulting in host protection and parasite resistance in the mouse model \[[@CR7], [@CR37]\]. *Leishmania infantum* LPG also triggered higher NO production \[[@CR36], [@CR38]\]. Interestingly, macrophages stimulated with *L. braziliensis* LPG had a higher TNFα, IL-1α, IL-6 and NO production than those stimulated with *L. infantum*, while a strong inhibition of NO production by LPS was observed after LPG incubation from both species \[[@CR38]\]. LPG from *L. tropica* is the most complex characterized to date, as most of the repeat units are substituted with more than 19 different glycan side chains \[[@CR37]\]. Furthermore, Ghoshal et al. \[[@CR39]\] showed that *Leishmania* species have a differential distribution of sialic acid (SA) on their surface despite their close pathogenesis resemblance. Thus, enhanced higher levels of SA serve as one of the potential determinants responsible for increased NO resistance and survivability of parasites by inhibition of host responses \[[@CR39]\]. In the present study, using SLA derived from *L. major* and *L. tropica* strains, we demonstrated a diminution of NO production in IFN-γ/ LPS stimulated macrophages.

This result is of importance given that it indicates that live pathogens differ in their ability to modulate NO production compared to that observed with SLAs. We have previously reported that only live parasites were capable to modulate macrophage's death \[[@CR5]\]. Furthermore, we recently demonstrated that infected macrophages, and not only those exposed to parasites (bystander), modulate cell host bioenergetics profile \[[@CR40]\], and affect dendritic function in inducing Th1 CD4 T cells expressing IL-10 \[[@CR41]\].

These first experiments were carried out with primary dermal strains passively isolated from patients consulting at Ibn Rochd Hospital of Casablanca (Morocco), which is not an endemic area of CL. The results showed a different NO modulation by these two strains representing *L. major* and *L. tropica* species*.* This led us to plan further experiments with additional strains from different endemic regions.

Conclusions {#Sec19}
===========

In Morocco, as well as in the other North African countries, CL due to *L. major* and *L. tropica* remains a serious public health concern. Our results suggest a distinct capacity of our primary strains to modulate NO production in order to survive in infected macrophages, which in turn may explain the different physiopathology of these species, especially the chronic tendency of *L. tropica* CL. *Leishmania tropica* is recognized as a very heterogeneous species and its intraspecific heterogeneity is readily demonstrated by many authors. Human infection caused by *L. tropica* seems to be more insidious compared with *L. major* infection. Therefore, although it remains to extend this observation to additional clinical primary strains, understanding the molecular mechanisms by which *L. tropica* subverses NO production could be essential for the control of this endemic infection.
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